Arrowstreet Capital’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$561K Sell
52,994
-5,601
-10% -$59.3K ﹤0.01% 1730
2025
Q1
$881K Sell
58,595
-860
-1% -$12.9K ﹤0.01% 1497
2024
Q4
$979K Sell
59,455
-49,338
-45% -$812K ﹤0.01% 1463
2024
Q3
$2.69M Hold
108,793
﹤0.01% 1153
2024
Q2
$2.76M Sell
108,793
-11,026
-9% -$279K ﹤0.01% 993
2024
Q1
$3.04M Sell
119,819
-102,691
-46% -$2.61M ﹤0.01% 1031
2023
Q4
$5.04M Buy
222,510
+83,396
+60% +$1.89M 0.01% 748
2023
Q3
$2.59M Buy
+139,114
New +$2.59M ﹤0.01% 797
2022
Q1
Sell
-29,906
Closed -$1.07M 1176
2021
Q4
$1.07M Buy
29,906
+210
+0.7% +$7.53K ﹤0.01% 1151
2021
Q3
$1.26M Sell
29,696
-20,365
-41% -$867K ﹤0.01% 1242
2021
Q2
$2.17M Buy
+50,061
New +$2.17M ﹤0.01% 1327
2020
Q3
Sell
-47,155
Closed -$1.78M 2311
2020
Q2
$1.78M Sell
47,155
-30,835
-40% -$1.16M ﹤0.01% 1532
2020
Q1
$2.26M Sell
77,990
-129,070
-62% -$3.73M 0.01% 1022
2019
Q4
$10.7M Buy
207,060
+124,973
+152% +$6.48M 0.03% 592
2019
Q3
$4.51M Buy
82,087
+3,224
+4% +$177K 0.01% 736
2019
Q2
$3.2M Buy
78,863
+19,300
+32% +$784K 0.01% 781
2019
Q1
$1.8M Buy
+59,563
New +$1.8M ﹤0.01% 1142
2016
Q4
Sell
-26,721
Closed -$1.28M 1624
2016
Q3
$1.28M Buy
+26,721
New +$1.28M ﹤0.01% 1020
2014
Q4
Sell
-17,236
Closed -$632K 1219
2014
Q3
$632K Sell
17,236
-24,303
-59% -$891K ﹤0.01% 795
2014
Q2
$1.93M Buy
41,539
+30,737
+285% +$1.42M 0.01% 599
2014
Q1
$444K Buy
+10,802
New +$444K ﹤0.01% 979